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Abstract
Background: Switzerland has a low mortality rate from cardiovascular diseases, but little is known regarding
prevalence and management of cardiovascular risk factors (CV RFs: hypertension, hypercholesterolemia and
diabetes) in the general population. In this study, we assessed 10-year trends in self-reported prevalence and
management of cardiovascular risk factors in Switzerland.
Methods: data from three national health interview surveys conducted between 1997 and 2007 in representative
samples of the Swiss adult population (49,261 subjects overall). Self-reported CV RFs prevalence, treatment and
control levels were computed. The sample was weighted to match the sex - and age distribution, geographical
location and nationality of the entire adult population of Switzerland.
Results: self-reported prevalence of hypertension, hypercholesterolemia and diabetes increased from 22.1%, 11.9%
and 3.3% in 1997 to 24.1%, 17.4% and 4.8% in 2007, respectively. Prevalence of self-reported treatment among
subjects with CV RFs also increased from 52.1%, 18.5% and 50.0% in 1997 to 60.4%, 38.8% and 53.3% in 2007 for
hypertension, hypercholesterolemia and diabetes, respectively. Self-reported control levels increased from 56.4%,
52.9% and 50.0% in 1997 to 80.6%, 75.1% and 53.3% in 2007 for hypertension, hypercholesterolemia and diabetes,
respectively. Finally, screening during the last 12 months increased from 84.5%, 86.5% and 87.4% in 1997 to 94.0%,
94.6% and 94.1% in 2007 for hypertension, hypercholesterolemia and diabetes, respectively.
Conclusion: in Switzerland, the prevalences of self-reported hypertension, hypercholesterolemia and diabetes have
increased between 1997 and 2007. Management and screening have improved, but further improvements can still
be achieved as over one third of subjects with reported CV RFs are not treated.
Background
Cardiovascular disease is the main cause of premature
death in industrialized countries, and its incidence is
increasing worldwide [1]. In Switzerland, between 1970
and 2004, mortality rates from ischemic heart and cere-
brovascular disease have decreased by circa 50% in men,
and by a third by women [2]. Whether those decreases
are due to a decrease in cardiovascular risk factors pre-
valence and/or management is currently unknown.
There are few data regarding trends of cardiovascular
risk factors in the Swiss population. The MONICA
study showed an increase between 1984 and 1993 in the
prevalence of hypertension in men and a decrease in
women. For the same time period, a decrease in the pre-
valence of hypercholesterolemia (defined as a total cho-
lesterol level > 6.5 mmol/L) was also reported for both
genders [3]. More recently, data from Geneva showed a
decrease in the prevalence of hypertension for both gen-
ders between 1993 and 2000. For the same period, an
increase in the prevalence of hypercholesterolemia was
reported [4]. Still, it is not known if the results of this
study also apply to the whole country. Thus, we used
the data from the National Health Surveys conducted in
representative samples of the Swiss population to assess
the trends in self-reported prevalence, treatment and
control of hypertension, hypercholesterolemia and
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diabetes in Switzerland, as well as to identify the groups
at higher risk.
Methods
Swiss Health Survey
Data from the Swiss Health Surveys (SHS) were
obtained from the Swiss Federal Statistical Office
(http://www.bfs.admin.ch). The SHS is a cross-sectional,
nationwide, population-based telephone survey con-
ducted every 5 years since 1992 (1992, 1997, 2002 and
2007) [5]. The SHS aims to track public health trends in
a representative sample of the resident population of
Switzerland aged 15 and over.
The study population was chosen by stratified random
sampling of a database of all private Swiss households
with fixed line telephones. It is currently estimated that
over 90% of the Swiss households have fixed telephones.
The first sampling stratum consisted of the seven main
regions: West “Léman”, West-Central “Mittelland”,
Northwest, Zurich, North-Eastern, Central and South.
The second stratum consisted of the cantons, and the
number of households drawn was proportional to the
population of the canton. In some cantons, oversam-
pling of the households was made to obtain accurate
cantonal estimates. Extra strata were used for two large
cantons of Zurich and Bern. Within these strata, house-
holds were randomly drawn and, within the household,
one member was randomly selected within all members
aged 15 years and over. A letter inviting this household
member to participate in the survey was sent, then
contacted by phone and interviewed using computer-
assisted software managing both dialling and data
collection. The interviews were carried out in German,
French or Italian, as appropriate. People who did not
speak any of these three languages were excluded from
the survey. Other criteria for exclusion were: asylum
seeker status, households without a fixed line telephone,
very poor health status and living in a nursing home [6].
Four sampling waves were performed (Winter, Spring,
Summer and Autumn). Participation rate was 71% in
1992, 85% in 1997, 64% in 2002, and 66% in 2007. More
details available at http://www.bfs.admin.ch/bfs/portal/
fr/index/infothek/erhebungen__quellen/blank/blank/ess/
04.html. As too many data were missing in 1992 (no
information on hypertension and diabetes), only data for
the three last surveys (1997, 2002 and 2007) was used.
Data collected
Three age categories were considered: 18 to 44, 45 to
64, and ≥ 65 years. Education was categorized as fol-
lows: 1) no education completed, 2) first level (primary
school), 3) lower secondary level, 4) upper secondary
level and 5) tertiary level, which included university and
other forms of education after the secondary level. We
defined “low education” (categories 1 and 2), “middle
education” (categories 3 and 4), and “high education”
(category 5) groups. Self reported height and weight
allowed the calculation of Body Mass Index (BMI).
Three BMI categories were considered: normal (< 25
kg/m2), overweight (≥ 25 to < 30 kg/m2) and obese (≥
30 kg/m2). Citizenship was defined as Swiss (having a
Swiss passport) or foreigner.
The self-reported prevalence of hypertension, hyperch-
olesterolemia or diabetes was assessed by the questions:
“Did a doctor or a health professional tell you that you
have high blood pressure/a high cholesterol level/dia-
betes?”, respectively. Subjects were considered as treated
for hypertension, hypercholesterolemia or diabetes if
they answered positively to the questions “Are you trea-
ted for blood pressure/to decrease your cholesterol
levels/for diabetes?” respectively. Self-reported preva-
lence of antihypertensive, hypolipidaemic or antidiabetic
treatment was calculated as the ratio of subjects report-
ing being treated by the number of subjects reporting
the disease (i.e. number of subjects reported being trea-
ted for hypertension divided by the number of subjects
reporting being hypertensive). A further question on
doctor-prescribed medicines was asked. All subjects
being treated were considered irrespective of the answer
to the latter question.
Adequate treatment of hypertension, hypercholestero-
lemia or diabetes was considered if the subjects
answered “normal or too low” to the questions: “Cur-
rently, how is your blood pressure/cholesterol level/gly-
caemia?” respectively. Self-reported prevalence of
adequate CV RF management was calculated as the
ratio of subjects reporting being treated and answering
“normal or too low” divided by the overall number of
subjects reporting being treated. Missing answers were
considered as negative (i.e. high levels). As the question-
naires changed slightly between surveys, some questions
were missing, i.e., the question on control of hyperten-
sion was not asked in 2002.
All subjects, irrespective of their status, were asked
when they last had their blood pressure, cholesterol or
glucose levels measured. Adequate screening was con-
sidered if the measurement had been performed during
the last 12 months.
Statistical analysis
Statistical analysis was conducted using Stata version 10
(Statacorp, College Station, TX, USA) and SAS Enterprise
Guide version 4.1 (SAS Inc, Cary, NC; USA). Results were
expressed as number of subjects and (percentage) or mean
± standard deviation. Comparisons were performed using
chi-square for categorical data or analysis of variance
(ANOVA) for continuous data. A first analysis was con-
ducted using the original data. A second analysis was
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conducted after probability weighting each subject accord-
ing to the formula
w H
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i
h
i
h
h
n= ⋅
Where Nh is the average number of telephone num-
bers in stratum h (h = 29), Hi is the household size, i.e.
the number of subjects aged 15 and over living in
household i, and nh
n is the number of telephone num-
bers in the sample Sh corresponding to stratum h to the
power n (n = sample size in stratum h). Weights were
further corrected taking into account the percentage of
nonresponders by raking ratio estimation [7]. Weighting
partly allowed the correction for bias, i.e. subjects with
given characteristics who are under-represented in the
original sample were attributed a higher weight [8]. The
sum of weights thus corresponds to the Swiss adult
population for the period considered. For simplicity, the
weighted results will be presented and commented, as
the conclusions arising from the unweighted data are
similar (see Additional file 1). A third analysis using
multivariate logistic regression adjusting for age group,
sex, nationality, education and BMI classes was con-
ducted to assess trends during the study period, using
either the original (see Additional file 1) or the weighted
data (presented here). The results were expressed as
Odds ratio and [95% confidence interval]. Statistical sig-
nificance was considered for p < 0.05.
Results
Characteristics of the subjects
The characteristics of subjects according to survey are
summarized in table 1. Between 1997 and 2007 mean
age increased and the percentage of subjects with low or
middle education decreased while the percentage of sub-
jects with high education increased.
Hypertension
The trends in self-reported prevalence of hypertension
are shown in table 2. Between 1997 and 2007, self-
reported hypertension in the Swiss general population
increased, and this was further confirmed after multi-
variate adjustment (table 3). Subjects aged over 65 years
or obese had a higher odds ratio, while subjects with
university level or foreigners had a lower odds ratio of
reporting being hypertensive (table 3). Self-reported
treatment increased (table 2); on multivariate analysis,
subjects aged over 45 or obese had a higher odds ratio,
while women and foreigners had a lower odds ratio of
reporting being treated (table 3). Self-reported preva-
lence of treatment prescribed by the doctor was 96.0%,
99.4% and 99.6% while the daily taking of an antihyper-
tensive drug was 89.6%, 95.3% and 97.1% in 1997, 2002
and 2007, respectively. The self-reported prevalence of
controlled hypertension increased and the self-reported
prevalence of uncontrolled and untreated hypertension
decreased (table 2); on multivariate adjustment, subjects
over 65 presented a higher odds ratio of reporting being
controlled (table 3). Hypertension screening also
increased (table 2), and on multivariate analysis, men,
foreigners, subjects aged over 45, overweight or obese
had a higher odds ratio of being screened (table 3).
Hypercholesterolemia
Self-reported prevalence of hypercholesterolemia
increased considerably between 1997 and 2007 (table 4)
and this increase was further confirmed by multivariate
analysis (table 5). Women, subjects over 45 years, with
higher education or presenting with overweight or
Table 1 characteristics of the samples
1997 2002 2007
Sum of weights 5,564,776 5,647,472 5,784,057
Women (%) 51.7 51.6 51.2
Age classes (%)
18-44 years 51.5 49.9 49.5
45-64 years 29.8 30.9 31.9
≥ 65 years 18.7 19.2 18.7
Swiss nationality (%) 81.7 80.5 79.5
Educational level (%)
Low § 22.6 20.4 12.8
Middle §§ 60.0 63.2 59.6
High §§§ 17.4 16.4 27.6
BMI classes (%)
Normal 63.8 61.3 61.0
Overweight 29.1 30.7 30.4
Obese 7.1 8.0 8.6
BMI [kg/m2] 24.2 ± 3.9 24.3 ± 4.0 24.4 ± 4.1
Age [years] 46.5 ± 17.6 47.2 ± 17.5 47.3 ± 17.6
Results are expressed as weighted percentage and average ± standard
deviation. § no education completed + first level (primary school). §§ lower +
upper secondary level. §§§ tertiary level + other education after secondary
level.
Table 2 trends in self-reported prevalence and
management of hypertension in the Swiss population,
1997 - 2007
1997 2002 2007
Sum of weights 5,564,776 5,647,472 5,784,057
Hypertension (%)
Screening 87.7 95.1 95.1
Prevalence 22.1 22.4 24.2
Treatment * 52.1 53.8 60.4
Control ** 56.4 80.6
Results are expressed as weighted percentage. *, among subjects reporting
being hypertensive; **, among treated subjects. -, data not available.
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obesity had higher odds of reporting being hypercholes-
terolemic (table 5).
Self-reported hypolipidemic drug treatment increased
between 1997 and 2007 (table 4); multivariate analysis
showed women, older subjects, subjects with a higher
education or presenting with overweight or obesity to
have higher odds of being treated (table 5). In 2007,
99.1% of hypolipidemic drug treatment was prescribed
by the doctor and daily medication use was reported by
94.8% of treated subjects. The self-reported prevalence
of controlled hypercholesterolemia increased (table 4);
on multivariate analysis, women, subjects over 45 years,
subjects with a medium and high education had a
higher odds ratio, while foreigners had a lower odds
ratio of reporting being adequately controlled (table 5).
Conversely, the self-reported prevalence of uncontrolled
and untreated hypercholesterolemia remained stable
(table 4). Hypercholesterolemia screening increased
(table 4); on multivariate analysis, a higher odds ratio of
being screened was found for foreigners, subjects aged
over 45, and in overweight or obese subjects, while
women, subjects with a medium and a high education
had a lower odds ratio of being screened (table 5).
Diabetes
Self-reported prevalence of diabetes increased between
1997 and 2007 (table 6), a finding confirmed by multi-
variate analysis (table 7) which also showed men and sub-
jects with increasing age or BMI to have a higher odds
ratio, while subjects with middle or high education had a
lower odds ratio of reporting being diabetic. Self-reported
prevalence of diabetes treatment increased (table 6); mul-
tivariate analysis showed men, subjects aged over 45 or
presenting with overweight or obesity to have a higher
odds ratio, while foreigners had a lower odds ratio of
being treated (table 7). Self-reported diabetes control also
increased and the self-reported prevalence of uncon-
trolled and untreated diabetes decreased (table 6); multi-
variate analysis showed subjects aged 45-64 years,
presenting with overweight or obesity or foreigners to
Table 3 multivariate analysis of the trends in self-reported prevalence and management of hypertension in the Swiss
population, 1997 - 2007
Prevalence Treatment* Control** Screening
Surveys
1997 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
2002 0.98 [0.97 - 0.99] 1.01 [1.01 - 1.02] - 2.73 [2.71 - 2.74]
2007 1.10 [1.09 - 1.11] 1.32 [1.31 - 1.33] 3.16 [3.13 - 3.18] 2.71 [2.70 - 2.72]
Gender
Woman 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Man 1.01 [1.00 - 1.02] 1.17 [1.16 - 1.18] 0.96 [0.95 - 0.96] 0.78 [0.77 - 0.79]
Age groups
18-44 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
45-64 2.79 [2.78 - 2.80] 4.96 [4.93 - 5.00] 1.89 [1.86 - 1.92] 1.36 [1.35 - 1.37]
≥ 65 7.36 [7.34 - 7.38] 15.1 [15.0 - 15.2] 1.68 [1.66 - 1.71] 2.39 [2.38 - 2.41]
Nationality
Swiss 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Other 0.90 [0.89 - 0.91] 0.91 [0.90 - 0.92] 0.56 [0.55 - 0.57] 1.25 [1.24 - 1.26]
Education
Low 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Medium 0.93 [0.93 - 0.94] 0.98 [0.97 - 0.99] 1.22 [1.21 - 1.23] 0.95 [0.95 - 0.96]
High 0.90 [0.89 - 0.91] 1.03 [1.02 - 1.04] 1.60 [1.58 - 1.62] 0.83 [0.82 - 0.84]
BMI classes
Normal 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Overweight 1.94 [1.93 - 1.95] 1.42 [1.41 - 1.43] 1.12 [1.11 - 1.13] 1.20 [1.19 - 1.21]
Obesity 4.23 [4.22 - 4.25] 1.98 [1.96 - 1.99] 1.07 [1.06 - 1.08] 1.57 [1.56 - 1.59]
Results are expressed as multivariate-adjusted odds ratio and [95% confidence interval]. *, among subjects with reported hypertension; **, among treated
subjects. -, data not available.
Table 4 trends in self-reported prevalence and
management of hypercholesterolemia in the Swiss
population, 1997 - 2007
1997 2002 2007
Sum of weights 5,564,776 5,647,472 5,784,057
Screening 86.5 94.6 93.8
Prevalence 11.9 14.7 17.4
Treatment * 18.5 32.2 38.8
Control ** 52.9 - 75.1
Results are expressed as weighted percentage. *, among subjects reporting
being hypercholesterolemic; **, among treated subjects. -, data not available.
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have a lower odds ratio, while high educated subjects had
a higher odds ratio of being controlled (table 7). Finally,
diabetes screening increased during the study period
(table 6) and multivariate analysis showed foreigners,
subjects aged over 45, overweight or obese to have a
higher odds ratio, while men and subjects with medium
or high education to have a lower odds ratio of being
screened (table 7).
Discussion
Since the MONICA study in the nineties [3] and the Bus
Santé study in Geneva [4], there has been little informa-
tion on trends of hypertension, hypercholesterolemia and
diabetes in Switzerland. The data from the Swiss National
Health Surveys thus provide important information
regarding the self-reported prevalence and management
of those cardiovascular risk factors in the Swiss popula-
tion. As the sampling frame covers about 90% of Swiss
households and the participation rate was relatively high
for all studies, this study is a good reflect of the Swiss
situation. The fact that the weighted and unweighted
results were quite similar also suggests the absence of
important bias.
Hypertension
Prevalence of self-reported hypertension increased
between 1997 and 2007 and was comparable to those
reported using measured data by US [9] and German [10]
studies and with other studies using self-reported data
(table 8). This increase could be due either to an increase
in the true prevalence of hypertension, to a more wide-
spread screening, or both. The second hypothesis might
be more likely, as the prevalence of subjects reporting hav-
ing their blood pressure measured during the previous
12 months also increased during this period, a finding
already reported in the literature [11]. Another likely deter-
minant is decrease in the thresholds to define hypertension
from ≥ 160/95 mmHg in 1993 [3] to ≥ 140/90 mmHg
afterwards. Still, self-reported prevalence rates are probably
Table 5 multivariate analysis of the trends in self-reported prevalence and management of hypercholesterolemia in
the Swiss population, 1997 - 2007
Prevalence Treatment* Control** Screening
Surveys
1997 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
2002 1.26 [1.25 - 1.27] 2.21 [2.19 - 2.22] - 2.77 [2.75 - 2.78]
2007 1.52 [1.51 - 1.53] 2.80 [2.78 - 2.82] 2.59 [2.55 - 2.63] 2.48 [2.47 - 2.49]
Gender
Woman 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Man 0.77 [0.76 - 0.78] 0.68 [0.67 - 0.69] 1.19 [1.18 - 1.21] 0.95 [0.95 - 0.96]
Age groups
18-44 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
45-64 3.53 [3.52 - 3.55] 4.11 [4.07 - 4.15] 0.96 [0.93 - 0.98] 0.74 [0.74 - 0.75]
≥ 65 5.11 [5.09 - 5.13] 10.3 [10.2 - 10.4] 1.17 [1.14 - 1.20] 1.03 [1.02 - 1.04]
Nationality
Swiss 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Other 1.02 [1.01 - 1.03] 1.02 [1.01 - 1.03] 0.74 [0.72 - 0.75] 1.01 [1.01 - 1.01]
Education
Low 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Medium 1.09 [1.08 - 1.10] 0.96 [0.95 - 0.97] 1.15 [1.13 - 1.17] 0.85 [0.84 - 0.85]
High 1.24 [1.23 - 1.25] 0.86 [0.85 - 0.87] 1.58 [1.54 - 1.61] 0.69 [0.68 - 0.69]
BMI classes
Normal 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Overweight 1.46 [1.45 - 1.47] 1.41 [1.40 - 1.42] 1.09 [1.08 - 1.10] 0.95 [0.95 - 0.96]
Obesity 1.67 [1.66 - 1.68] 1.82 [1.80 - 1.83] 1.04 [1.02 - 1.06] 1.03 [1.02 - 1.03]
Results are expressed as multivariate-adjusted odds ratio and [95% confidence interval]. *, among subjects with reported hypercholesterolemia; **, among treated
subjects.-, data not available.
Table 6 trends in self-reported prevalence and
management of diabetes in the Swiss population,
1997 - 2007
1997 2002 2007
Sum of weights 5,564,776 5,647,472 5,784,057
Diabetes (%)
Screening 87.4 94.9 94.1
Prevalence 3.3 3.7 4.8
Treatment (drug) * 50.0 - 53.3
Control ** 50.5 - 65.5
Results are expressed as weighted percentage. *, among subjects reporting
being diabetic; **, among treated subjects. -, data not available.
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underestimated, as a recent study conducted in Lausanne
has shown that less than two thirds of hypertensive sub-
jects are actually aware of their condition [12].
A higher prevalence of reported hypertension was
found among subjects aged over 45 years or presenting
with overweight or obesity. Those findings are in agree-
ment with the literature [9,13,14] and might be due to
an increased screening with age or because of the pre-
sence of other risk factors [15]. Conversely, foreigners
had a lower self-reported prevalence of hypertension,
and this could not be attributed to a lower screening
frequency or to differences in age or BMI status. Possi-
ble explanations include differences in dietary or genetic
background, but further studies are needed to better
assess this point. The self-reported prevalence of hyper-
tension was also inversely related with educational level,
a finding in agreement with the literature [16]. This
finding might be related to a better lifestyle, namely
regarding dietary salt intake, although data from the
Geneva study showed no improvement in salt intake in
the general population [17].
Self-reported treatment of hypertension increased dur-
ing the study period, suggesting an improvement in the
management of this risk factor. Still, in 2007, only six
out of ten hypertensive subjects indicated they were on
antihypertensive treatment. Although the remaining 40%
might be under nonpharmacological antihypertensive
measures such as diet or specific lifestyle modifications,
our findings suggest that there is still room for improve-
ment regarding pharmacological management of hyper-
tension, a finding reported previously [12].
In agreement with objectively measured data from the
US [9,13] and France [18], an increase in self-reported
control of hypertension was found for the period
1997-2007. This increase might be related to an
improvement in antihypertensive treatment, namely the
appearance of more potent and new antihypertensive
drugs, and/or an improvement of subject’s compliance.
Still, our results are probably overestimated because
some treated subjects might report being controlled just
because they are taking antihypertensive drugs. Indeed,
a previous study conducted in Lausanne showed that a
consistent fraction of treated hypertensive subjects actu-
ally presented with high blood pressure levels [12].
Hence, it is likely that the true prevalence of controlled
hypertension in Switzerland might actually be lower.
Nevertheless, the fact that the self-reported prevalence
of uncontrolled and untreated hypertension also
decreased suggests that the overall management of
hypertension in the Swiss population is improving.
Table 7 multivariate analysis of the trends in self-reported prevalence and management of diabetes in the Swiss
population, 1997 - 2007
Prevalence Treatment * Control ** Screening
Surveys
1997 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
2002 1.10 [1.09 - 1.10] - - 2.68 [2.67 - 2.69]
2007 1.49 [1.48 - 1.50] 1.16 [1.15 - 1.18] 1.92 [1.88 - 1.95] 2.43 [2.42 - 2.45]
Gender
Woman 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Man 1.20 [1.19 - 1.20] 1.24 [1.23 - 1.26] 0.91 [0.90 - 0.93] 1.04 [1.04 - 1.04]
Age groups
18-44 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
45-64 2.96 [2.94 - 2.98] 2.78 [2.73 - 2.84] 0.62 [0.60 - 0.65] 0.86 [0.86 - 0.87]
≥ 65 6.78 [6.73 - 6.83] 5.23 [5.13 - 5.34] 0.79 [0.76 - 0.82] 1.19 [1.19 - 1.20]
Nationality
Swiss 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Other 0.95 [0.95 - 0.96] 0.74 [0.73 - 0.76] 0.51 [0.50 - 0.52] 1.01 [1.00 - 1.01]
Education
Low 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Medium 0.79 [0.79 - 0.80] 1.46 [1.43 - 1.48] 1.13 [1.10 - 1.15] 0.87 [0.87 - 0.88]
High 0.75 [0.75 - 0.76] 1.00 [0.98 - 1.02] 1.86 [1.81 - 1.92] 0.64 [0.64 - 0.65]
BMI classes
Normal 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Overweight 1.64 [1.63 - 1.65] 1.63 [1.61 - 1.66] 1.15 [1.12 - 1.17] 0.95 [0.94 - 0.95]
Obesity 3.71 [3.68 - 3.73] 2.24 [2.20 - 2.27] 0.84 [0.82 - 0.86] 1.02 [1.01 - 1.03]
Results are expressed as multivariate-adjusted odds ratio and [95% confidence interval]. *, among subjects with reported diabetes; **, among treated subjects. -,
data not available.
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Hypercholesterolemia
Self-reported prevalence of hypercholesterolemia was
within values published for other countries which used
self-reported data (table 8), but lower than the values
obtained in a smaller Swiss population-based study
using objectively measured data (table 9). Still, and in
agreement with previous Swiss [4], French [18] and Ger-
man [10] studies based on objectively measured data
and with studies using self-reported data, the self-
reported prevalence of hypercholesterolemia increased
between 1997 and 2007. As for hypertension, possible
explanations include a true increase in the prevalence of
hypercholesterolemia, an increase in screening, a
decrease in the threshold values to define hypercholes-
terolemia [19] or a mixture of them. Interestingly, cho-
lesterol screening increased considerably during the
study period, and the prevalence of subjects reporting
having their blood cholesterol levels assessed during the
previous 12 months was actually higher than other stu-
dies [11]. Still, in 2007, the self-reported prevalence of
hypercholesterolemia in Switzerland was lower than the
USA [11] or France [18]. Two explanations are possible,
i.e. the prevalence of hypercholesterolemia being indeed
lower in Switzerland, or a lower screening by Swiss GPs.
Indeed, it has been shown that only 75% of Swiss physi-
cians consider that screening for high cholesterol is very
important, versus 93% for blood pressure [20]. Those
differences could partly explain the lower percentage of
self-reported hypercholesterolemia relative to
hypertension.
A higher self-reported prevalence of hypercholestero-
lemia was found among subjects aged over 45 years,
with high education or presenting with overweight or
obesity in agreement with other studies [16,18] but not
with others [21]. Still, our results suggest that, contrary
to hypertension, a higher education is related to a higher
self-reported prevalence of hypercholesterolemia. This
higher self-reported prevalence is not due to higher
screening rates among highly educated subjects, as their
odds of being screened were significantly lower (table 4).
A possible explanation is the fact that highly educated
subjects know better their medical situation [22], but
again further studies are needed to better assess this
point.
The self reported hypolipidemic treatment doubled
during the study period, in line with other French [18]
and German [10] studies. Nevertheless, in 2007, only four
out of ten Swiss patients who had been told they pre-
sented with hypercholesterolemia reported being treated,
a value similar to the one reported in the CoLaus study
[23] (table 9). Although diet has been shown to lower
cholesterol levels [24], it is unlikely that 60% of patients
diagnosed with hypercholesterolemia are on a diet alone.
Hence, and as for hypertension, our findings suggest that
there is room for improvement regarding pharmacologi-
cal management of hypercholesterolemia.
An increase in self-reported control of hypercholester-
olemia was found, a finding also found in other coun-
tries [18,25]. Two hypotheses are possible, i.e. an
improvement in hypolipidemic drugs and/or subject’s
Table 8 trends in self-reported prevalence of
cardiovascular risk factors in Switzerland and in other
countries
Switzerland Spain Greece USA France
Hypertension
1997 22.1 11.4 24.4
1999 25.4
2001 14.5
2002 22.4 20.1
2003 14.5
2006 25.7
2007 24.2
Dyslipidaemia
1997 11.9 8.2 26.6
1999 27.7
2001 11.0
2002 14.7 17.5
2003 10.5
2006 22.3
2007 17.4
Diabetes
1997 3.3 5.0 6.5 8.5
1999 7.1
2001 5.6
2002 3.7 8.7
2003 5.9
2006 10.3
2007 4.8
References: Switzerland 1, current study; Spain, [21]; Greece, [28]; USA, [29];
France, [18].
Table 9 comparison of prevalences or hypertension and
hypercholesterolaemia based on self-reported and
measured data for subjects aged 35-75, Switzerland
Switzerland
2002
Switzerland
2007
CoLaus
2003-6
Hypertension
Prevalence 26.2 27.5 36.0
Treatment * 54.7 62.4 78.0
Control ** - 83.0 48.0
Hypercholesterolaemia
Prevalence 18.6 22.4 29.0
Treatment * 32.7 40.4 40.0
Control ** - 77.1 58.0
Results are expressed as percentage. *, among subjects with the selected risk
factor; **, among treated subjects. CoLaus data from [12] for hypertension and
from [23] for hypercholesterolemia.
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compliance. Again, these results are certainly overesti-
mated, either because the subjects believed they were
controlled just because they were treated, or because
their GP considered them as treated despite borderline
high values [26].
Diabetes
The self-reported prevalence of diabetes increased during
period 1997-2007. Still, in 2007, the self-reported preva-
lence was lower than reported for France [18] or the US
[27], probably due to the self-reported (instead of objec-
tively measured) diabetic status. Still, comparing our data
with self-reported data from other countries [18,21,28,29]
led to similar conclusions (table 8). Possible explanations
include the relatively low prevalence of obesity in
Switzerland [30,31] albeit other factors might be at play.
Interestingly, the increase in the self-reported prevalence
of diabetes persisted after adjustment for overweight and
obesity, suggesting that other factors might intervene
[32], namely a better screening. Indeed, the prevalence of
subjects reporting having their blood glucose assessed
the previous 12 months increased between 1997 and
2007, a finding in agreement with other studies [33,34].
Also in agreement with the literature [32], a higher
self-reported prevalence of diabetes was found among
men, subjects aged over 45 years or presenting with
overweight or obesity. Similarly, and as reported pre-
viously [16,32], a lower prevalence of self-reported dia-
betes was found among subjects with high educational
level. High educated subjects could have more financial
means to adapt their lifestyle, e.g., to buy higher quality
food [35] or exercise more, thus preventing the occur-
rence of diabetes. They could better know their health
state despite less screened, but further studies are
needed to better assess this point.
Self reported antidiabetic treatment increased, a trend
also reported for France [18] and Italy [36]. Still and
again, in 2007, only half of the subjects diagnosed with
diabetes reported being treated, and, as for hypercholes-
terolemia, it is rather unlikely that the remaining half
was only on diet. Overall, our data indicate that, in
Switzerland, many diabetic subjects are probably under-
treated, and that further efforts should be made to
implement (non) pharmacological treatment.
The increase in self-reported diabetic control found in
this study has also been reported elsewhere [25]. This
improvement is probably due to a change in therapies
and/or an improvement of the subject’s compliance.
Still, in 2007, one third of treated diabetic subjects
reported having high glycaemia, and again this figure is
certainly underestimated because many treated subjects
believed they are controlled simply due to the fact they
receive a drug. Nevertheless, the fact that the prevalence
of uncontrolled and untreated diabetes also decreased
suggests that the overall management of diabetes in the
Swiss population is improving.
Limitations
First, and as indicated previously, the self-reporting of
the cardiovascular risk factors might underestimate the
real prevalence in the population, as it can be inferred
from the results of table 9. Still, it represents the result
of the screening done by doctors and health profes-
sionals and has been used in other studies for the
assessment of trends [21,28,29,37]. Further, it has been
shown that self-reported data on cardiovascular risk fac-
tors is valid and can be used to assess prevalence rates
in most cases [38,39]. Second, increasing rates occurred
mainly between 2002 and 2007, when the sample
becomes much more educated, raising the issue of a
possible selection bias, more educated participants tend-
ing to respond more easily. The presence of other
unmeasured confounders such as changes in dietary
intake could also influence results. Since other unmea-
sured predictors of disease treatment and control were
likely to change along with education, the trends in
treatment and control are thus likely to be biased away
from the null. Still, in the absence of another nationally
representative sample, this study provides the best esti-
mates regarding self-reported prevalence and manage-
ment of cardiovascular risk factors. Third, the fact that
the unweighted and weighted estimates are similar does
not remove the potential for response bias. Still, the
weighting procedure gives some strata which are less
represented in the sample (i.e. young males) a higher
weight, thus partially reducing this bias. It should be
noted that some studies only standardized on age [29]
or even made no adjustment [28], while in this study
weighting included gender, age, geographical location
and nationality [8]. Forth, although several studies con-
ducted in the USA [40,41] indicate a high level of
undiagnosed hypertension and hypercholesterolemia
among uninsured subjects, this is rather unlikely to
occur in Switzerland as all subjects living in Switzerland
have a health insurance (federal law 832.10 of march
18th, 1994, available at http://www.admin.ch/ch/f/rs/
c832_10.html). Still, as a nontrivial percentage of sub-
jects with hypertension, dyslipidemia or diabetes might
be unaware of their status [12,42], our prevalence esti-
mates might be underestimated. Finally, no information
was available regarding nonpharmacological treatment
of cardiovascular risk factors, so it was not possible to
assess the percentage of subjects not treated with drugs
but with other nonpharmacological measures.
Conclusion
In Switzerland, self-reported prevalence of hypertension,
hypercholesterolemia and diabetes have increased
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between 1997 and 2007. Management and screening
have improved, but further improvements can still be
achieved as over one third of subjects with reported CV
RFs are not treated.
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